Literature DB >> 2826804

Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro.

C L Wilcox1, E M Johnson.   

Abstract

Primary sympathetic neuronal cultures were maintained for up to 5 weeks after inoculation with herpes simplex virus (HSV) without evidence of viral infection. Treatment with acyclovir for the first 7 days after viral inoculation prevented lytic infections in 100% of the cultures and resulted in viral latency in 100% of the cultures; reactivation occurred as the result of nerve growth factor (NGF) deprivation. Treatment of the cultures with several different inhibitors of viral DNA polymerase (acyclovir, aphidicolin, and phosphonoacetic acid) for 7 days after viral inoculation did not prevent the establishment of latency, which suggests that viral DNA replication was not required. During the latent phase of the infection, viral antigens were not detected with HSV-specific immunohistochemistry. However, 24 h after NGF deprivation, viral antigens were detected in essentially all of the neurons, indicating that the majority of neurons harbored latent HSV. The establishment of latency was not strain or type specific since latency was established with HSV type 2 and four strains of HSV type 1 and reactivation occurred in response to NGF deprivation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2826804      PMCID: PMC250548          DOI: 10.1128/JVI.62.2.393-399.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Latent infection of the peripheral ANS with herpes simplex virus.

Authors:  R W Price; B J Katz; A L Notkins
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

2.  Effect of nerve growth factor on synaptic depression after axotomy.

Authors:  D Purves; A Njå
Journal:  Nature       Date:  1976-04-08       Impact factor: 49.962

3.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors:  G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  The effects of nerve growth factor and its antiserum on synapses in the superior cervical ganglion of the guinea-pig.

Authors:  A Njå; D Purves
Journal:  J Physiol       Date:  1978-04       Impact factor: 5.182

5.  Temperature-sensitive mutants of herpes simplex virus differ in the capacity to establish latent infections in mice.

Authors:  K W Lofgren; J G Stevens; H S Marsden; J H Subak-Sharpe
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

6.  Requirement of protein synthesis for the degradation of host mRNA in Friend erythroleukemia cells infected wtih herpes simplex virus type 1.

Authors:  Y Nishioka; S Silverstein
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

7.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

8.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

9.  The nerve growth factor: purification as a 30,000-molecular-weight protein.

Authors:  V Bocchini; P U Angeletti
Journal:  Proc Natl Acad Sci U S A       Date:  1969-10       Impact factor: 11.205

10.  The retrograde axonal transport of nerve growth factor.

Authors:  I A Hendry; K Stöckel; H Thoenen; L L Iversen
Journal:  Brain Res       Date:  1974-03-15       Impact factor: 3.252

View more
  62 in total

1.  Infection of human NT2 cells and differentiated NT-neurons with herpes simplex virus and replication-incompetent herpes simplex virus vectors.

Authors:  J P Weir
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

2.  Analysis of HSV Viral Reactivation in Explants of Sensory Neurons.

Authors:  Jesse H Arbuckle; Anne-Marie W Turner; Thomas M Kristie
Journal:  Curr Protoc Microbiol       Date:  2014-11-03

3.  An Immortalized Human Dorsal Root Ganglion Cell Line Provides a Novel Context To Study Herpes Simplex Virus 1 Latency and Reactivation.

Authors:  Nikki M Thellman; Carolyn Botting; Zachary Madaj; Steven J Triezenberg
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

4.  An antigen encoded by the latency-associated transcript in neuronal cell cultures latently infected with herpes simplex virus type 1.

Authors:  C Doerig; L I Pizer; C L Wilcox
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

5.  Stress and reactivation of latent herpes simplex virus: a fusion of behavioral medicine and molecular biology.

Authors:  F J Jenkins; A Baum
Journal:  Ann Behav Med       Date:  1995

6.  Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency.

Authors:  T M Kristie; J L Vogel; A E Sears
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

7.  Herpes simplex virus gene expression in neurons: viral DNA synthesis is a critical regulatory event in the branch point between the lytic and latent pathways.

Authors:  P F Nichol; J Y Chang; E M Johnson; P D Olivo
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

Review 8.  Human herpesviruses: a consideration of the latent state.

Authors:  J G Stevens
Journal:  Microbiol Rev       Date:  1989-09

9.  Lund Human Mesencephalic (LUHMES) Neuronal Cell Line Supports Herpes Simplex Virus 1 Latency In Vitro.

Authors:  Terri G Edwards; David C Bloom
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

10.  Topical treatment with nerve growth factor in an animal model of herpetic keratitis.

Authors:  Alessandro Lambiase; Marco Coassin; Nicola Costa; Paolo Lauretti; Alessandra Micera; Emiliano Ghinelli; Luigi Aloe; Paolo Rama; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-04       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.